JP MORGAN/CALL/TELADOC HEALTH/30/0.1/17.01.25 Stock

Warrant

DE000JL26265

Market Closed - Börse Stuttgart 04:53:26 2024-06-14 EDT
0.01 EUR -23.08% Intraday chart for JP MORGAN/CALL/TELADOC HEALTH/30/0.1/17.01.25
Current month-44.44%
1 month-44.44%
Date Price Change
24-06-14 0.01 -23.08%
24-06-13 0.013 0.00%
24-06-12 0.013 -7.14%
24-06-11 0.014 0.00%
24-06-10 0.014 -12.50%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 04:53 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying TELADOC HEALTH, INC.
Issuer J.P. Morgan
WKN JL2626
ISINDE000JL26265
Date issued 2023-04-17
Strike 30 $
Maturity 2025-01-17 (216 Days)
Parity 10 : 1
Emission price 0.72
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.86
Lowest since issue 0.01
Delta0.09x
Omega 4.276
Premium202.09x
Gearing47.91x
Moneyness 0.3333
Difference Strike 20 $
Difference Strike %+66.67%
Spread 0.015
Spread %55.56%
Theoretical value 0.0195
Implied Volatility 82.99 %
Total Loss Probability 97.64 %
Intrinsic value 0.000000
Present value 0.0195
Break even 30.21 €
Theta-0x
Vega0x
Rho0x

Company Profile

Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Sector
-
More about the company

Ratings for Teladoc Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Consensus: Teladoc Health, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
27
Last Close Price
10 USD
Average target price
16.71 USD
Spread / Average Target
+67.14%
Consensus